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ABSTRACT Human immunodeﬁciency virus (HIV) infection is the major risk factor
predisposing for Mycobacterium tuberculosis progression from latent tuberculosis in-
fection (LTBI) to tuberculosis disease (TB). Since long-term-treated aviremic HIV-
infected individuals remained at higher risk of developing TB than HIV-uninfected in-
dividuals, we hypothesized that progression from LTBI to pulmonary TB (PTB) might
be due not only to CD4 T-cell depletion but also to M. tuberculosis-speciﬁc CD4
T-cell functional impairment. To test this hypothesis, M. tuberculosis-speciﬁc T-cell
frequencies and cytokine proﬁles were investigated in untreated Tanzanian individu-
als suffering from LTBI (n  20) or PTB (n  67) and compared to those of un-
treated M. tuberculosis/HIV-coinfected individuals suffering from LTBI (n  15) or PTB
(n  10). We showed that HIV infection signiﬁcantly reduced the proportion of Th2
(interleukin 4 [IL-4]/IL-5/IL-13) producing M. tuberculosis-speciﬁc CD4 T cells and IL-2-
producing M. tuberculosis-speciﬁc CD4 and CD8 T cells in individuals with LTBI or
PTB (P 0.05). Interestingly, the loss of IL-2 production was associated with a signiﬁ-
cant increase of PD-1 expression on M. tuberculosis-speciﬁc CD4 and CD8 T cells
(P 0.05), while the loss of Th2 cytokine production was associated with a signiﬁ-
cant reduction of Gata-3 expression in memory CD4 T cells (P 0.05). Finally, we
showed that the serum levels of IL-1, IL-6, C-reactive protein (CRP), IL-23, and IP-10
were signiﬁcantly reduced in M. tuberculosis/HIV-coinfected individuals with PTB com-
pared to those in HIV-negative individuals with PTB (P 0.05), suggesting that HIV infec-
tion signiﬁcantly suppresses M. tuberculosis-induced systemic proinﬂammatory cytokine
responses. Taken together, this study suggests that in addition to depleting M.
tuberculosis-speciﬁc CD4 T cells, HIV infection signiﬁcantly impairs functionally favor-
able M. tuberculosis-speciﬁc CD4 T-cell responses in Tanzanian individuals with LTBI
or PTB.
IMPORTANCE Mycobacterium tuberculosis and human immunodeﬁciency virus (HIV)
infections are coendemic in several regions of the world, and M. tuberculosis/HIV-
coinfected individuals are more susceptible to progression to tuberculosis dis-
ease. We therefore hypothesized that HIV infection would potentially impair M.
tuberculosis-speciﬁc protective immunity in individuals suffering from latent tubercu-
losis infection (LTBI) or active pulmonary tuberculosis (PTB). In this study, we demon-
strated that M. tuberculosis/HIV-coinfected individuals have fewer circulating M.
tuberculosis-speciﬁc CD4 T cells and that those that remained were functionally im-
paired in both LTBI and PTB settings. In addition, we showed that HIV infection sig-
niﬁcantly interferes with M. tuberculosis-induced systemic proinﬂammatory cytokine/
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chemokine responses. Taken together, these data suggest that HIV infection impairs
functionally favorable M. tuberculosis-speciﬁc immunity.
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Mycobacterium tuberculosis and type 1 human immunodeﬁciency virus (HIV-1)infections are coendemic in several regions of the world. In 2017, the World
Health Organization (WHO) estimated that 1.7 billion individuals were infected with
M. tuberculosis, among whom 9 to 11 million individuals suffered from tuberculosis
disease (TB) (https://www.who.int/tb/publications/global_report/en/). Worldwide,
about 1.3 million individuals were M. tuberculosis/HIV-1 coinfected (https://www.who
.int/tb/publications/global_report/en/). The risk of developing TB increases throughout
the course of HIV infection and with HIV/AIDS disease progression (1) and was esti-
mated to be between 16- and 27-fold higher in HIV-infected individuals than in
HIV-uninfected individuals (2–5).
These observations demonstrate that HIV-1 infection represents one of the major risk
factors predisposing to TB development and suggest that protectiveM. tuberculosis-speciﬁc
immunity is probably altered by HIV infection.
Although only partially deﬁned (6), the protective components of M. tuberculosis-
speciﬁc immunity include appropriate and efﬁcient CD4 T-cell responses associated
with type 1 cytokine secretion (gamma interferon [IFN-] and tumor necrosis factor
alpha [TNF-]), since IFN- receptor deﬁciency is associated with increased suscepti-
bility to mycobacterial infections (7, 8) and anti-TNF- therapy is associated with
increased risk of TB reactivation (9).
HIV-1 infection triggers massive depletion of CD4 T cells (10), and it was ﬁrst
proposed that the increased risk to develop TB upon HIV infection might by associated
with the severe reduction of CD4 T-cell numbers (11). In this context, several studies
assessed the frequencies of M. tuberculosis-speciﬁc CD4 T cells in individuals suffering
from latent tuberculosis infection (LTBI) or TB coinfected or not with HIV in the presence
(12, 13) or absence (12–15) of conventional antiretroviral therapy (cART). The authors
showed that HIV infection profoundly affects the frequencies and the differentiation
proﬁle of M. tuberculosis-speciﬁc CD4 T cells that cART initiation partially restored (12,
13), supporting the aforementioned hypothesis. However, long-term cART-treated and
aviremic HIV-infected individuals remain at higher risk of developing TB than for
HIV-uninfected individuals (16), suggesting that increased risk of developing TB in
HIV-infected individuals might also be associated with M. tuberculosis-speciﬁc T-cell
impairment and/or altered M. tuberculosis-speciﬁc innate immunity.
Antigen-speciﬁc T-cell impairment has been described in the context of chronic viral
infections (17–19) or cancer (20) and is deﬁned by a progressive loss of T-cell functions,
including T-cell proliferation, cytokine production, and cytotoxic capacity (21). In this
study, we hypothesized that progression from LTBI to PTB might be due not only to
CD4 T-cell depletion but also to M. tuberculosis-speciﬁc CD4 T-cell functional impair-
ment and/or alteredM. tuberculosis-speciﬁc innate immunity. To test this hypothesis,M.
tuberculosis-speciﬁc CD4 and CD8 T-cell frequencies and cytokine proﬁles were inves-
tigated in untreated Tanzanian individuals with LTBI or PTB and compared to those of
untreated M. tuberculosis/HIV-coinfected individuals suffering from LTBI or PTB.
RESULTS
The present study aimed to determine the inﬂuence of HIV infection on M.
tuberculosis-speciﬁc T-cell responses in individuals with LTBI or PTB. Therefore, we
analyzed the cytokine proﬁle and cell lineage T-cell transcription factor expression
together with the differentiation proﬁle and the level of PD-1 expression of M.
tuberculosis-speciﬁc CD4 and CD8 T cells in 112 individuals recruited from Tanzania
(Table 1). The volunteers were screened for M. tuberculosis and HIV infection status and
stratiﬁed into four groups: (i) HIV-uninfected individuals with LTBI (referred to as
individuals with LTBI; n  20), (ii) HIV-infected individuals with LTBI (referred to as
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individuals with HIV/LTBI; n  15), (iii) HIV-uninfected individuals with PTB (referred to
as individuals with PTB; n  67), and (iv) HIV-infected individuals with PTB (referred to
as individuals with HIV/PTB; n  10).
HIV infection inﬂuences M. tuberculosis-speciﬁc CD4 T-cell frequencies and
cytokine proﬁles. The frequencies and functional proﬁles of M. tuberculosis-speciﬁc
CD4 T-cell responses were assessed by intracellular cytokine staining (ICS) according to
the gating strategy shown in Fig. 1A. In particular, the ability of antigen-speciﬁc CD4 T
cells to produce IFN-, TNF-, IL-2, IL-4, IL-5, and/or IL-13 in response to M. tuberculosis
(ESAT-6 and CFP-10 peptide pools) or HAd5 (hexon-derived overlapping peptide pool)
antigen-speciﬁc stimulation was assessed by multiparametric ﬂow cytometry in 20 LTBI
and 67 PTB individuals and compared to that in 15 HIV/LTBI- and 8 HIV/PTB-coinfected
individuals. Of note, Th2 cytokines, i.e., IL-4, IL-5, and IL-13, were all assessed in the
same ﬂow cytometry ﬂuorescence channel, which allowed the assessment of total Th2
cytokine production but prevented direct identiﬁcation of individual IL-4, IL-5, or IL-13
antigen-speciﬁc CD4 T-cell responses.
Cytokine proﬁles of M. tuberculosis-speciﬁc CD4 T cells from representative individ-
uals with LTBI, HIV/LTBI, PTB, and HIV/PTB are shown in Fig. 1B. We ﬁrst compared the
frequencies of cytokine-producing M. tuberculosis-speciﬁc memory CD4 T cells from
individuals with LTBI or PTB versus coinfected individuals, i.e., those with HIV/LTBI or
HIV/PTB, respectively (Fig. 2A). The cumulative data showed that TNF--, IFN--, IL-2-, or
IL-4/5/13-producing M. tuberculosis-speciﬁc memory CD4 T-cell frequencies were sig-
niﬁcantly reduced in individuals with HIV/LTBI compared to individuals with LTBI
(P 0.05) (Fig. 2A). In addition, IL-2- or IL-4/5/13-producing M. tuberculosis-speciﬁc
memory CD4 T-cell frequencies were signiﬁcantly reduced in individuals with HIV/PTB
compared to individuals with PTB (P 0.05), while IFN-- or TNF--producing M.
tuberculosis-speciﬁc memory CD4 T-cell frequencies were not signiﬁcantly different
between individuals with PTB coinfected or not with HIV (P 0.3744 and P 0.1096,
respectively) (Fig. 2A). Interestingly, no signiﬁcant differences were observed for TNF--,
IFN--, IL-2-, or IL-4/5/13-producing M. tuberculosis-speciﬁc memory CD4 T-cell frequen-
cies between individuals with LTBI and PTB or between individuals with HIV/LTBI and
HIV/PTB (P 0.05) (Fig. 2A).
We next analyzed the cytokine proﬁle of M. tuberculosis-speciﬁc memory CD4 T cells
of individuals with LTBI, LTBI/HIV, PTB, and HIV/PTB (Fig. 2B, pie charts). The cytokine
proﬁles of M. tuberculosis-speciﬁc memory CD4 T cells of individuals with LTBI or PTB
were signiﬁcantly different from those of individuals with HIV/LTBI or HIV/PTB, respec-
tively (P 0.05) (Fig. 2B, pie charts). Again, no signiﬁcant differences were observed
between individuals with LTBI and PTB or between individuals with HIV/LTBI and
HIV/PTB (P 0.05) (Fig. 2B, pie charts).
In-depth analysis showed that M. tuberculosis-speciﬁc CD4 T-cell responses of indi-
viduals with LTBI or PTB were signiﬁcantly enriched in polyfunctional IFN- IL-2
TNF- IL-4/5/13 CD4 T cells (triple IFN-/IL-2/TNF- M. tuberculosis-speciﬁc CD4 T
cells), dual IFN-/IL-2 CD4 T cells, and IFN- IL-2 TNF- IL-4/5/13 CD4 T-cell
populations (single IL-4/5/13 M. tuberculosis-speciﬁc CD4 T cells) compared to those
of individuals with HIV/LTBI or HIV/PTB (P 0.05) (Fig. 2B). In contrast, M. tuberculosis-
speciﬁc CD4 T-cell responses of individuals with HIV/LTBI or HIV/PTB were signiﬁcantly
enriched in IFN- IL-2 TNF- IL-4/5/13 CD4 T-cell populations (single IFN- M.
tuberculosis-speciﬁc CD4 T cells) and IFN- IL-2 TNF- IL-4/5/13 (dual IFN-/
TABLE 1 Demographic and clinical dataa
Infection type No. of subjects Median age, yrs (IQR) Sex No. of HIV-1 RNA copies/ml (IQR) CD4 count, cells/mm3 (IQR) CT value
LTBI 20 24.4 (20.4–34.6) 15 M/5 F NA NA NA
HIV/LTBI 15 35.9 (31.7–39.6) 3 M/12 F 6,810 (1,585–48,300) 618 (535–685) NA
PTB 67 28.5 (24–33) 46 M/21 F NA NA 19
HIV/PTB 10 33.5 (27.2–45.5) 6 M/4 F 115,800 (13,300–592,000) 291 (267–416) 19
aLTBI, latent tuberculosis infection; HIV, human immunodeﬁciency virus; PTB, pulmonary tuberculosis; M, male; F, female; NA, not applicable; IQR, interquartile range;
CT, threshold cycle.
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TNF- M. tuberculosis-speciﬁc CD4 T cells) compared to those of individuals with LTBI
or with PTB (P 0.05) (Fig. 2B). No signiﬁcant differences were observed among
cytokine-producing M. tuberculosis-speciﬁc memory CD4 T-cell frequencies between
individuals with LTBI and PTB or between individuals with HIV/LTBI and HIV/PTB
(P 0.05) (Fig. 2B).
FIG 1 Assessment of M. tuberculosis-speciﬁc CD4 T-cell responses. (A) Gating strategy used to assess cytokine-producing CD4 T cells. (B) Representative ﬂow
cytometry proﬁle of M. tuberculosis-speciﬁc CD4 T cells producing IFN-, IL-4/5/13, TNF-, and/or IL-2 of individuals with LTBI (62045), HIV/LTBI (65), PTB (60060),
or HIV/PTB (833). Cytokine proﬁles of CD4 T cells stimulated with SEB (positive control) or left unstimulated (negative control) are also shown.
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FIG 2 HIV infection inﬂuences M. tuberculosis-speciﬁc CD4 T-cell frequencies and cytokine proﬁles. (A) Percentage of M. tuberculosis-speciﬁc CD4 T cells
producing TNF-, IFN-, IL-2, or IL-4/5/13 of individuals with LTBI (n  20), HIV/LTBI (n  15), PTB (n  67), or HIV/PTB (n  8). (B) Proportion of M.
tuberculosis-speciﬁc CD4 T-cell populations producing IFN-, IL-4/5/13, TNF-, and/or IL-2 of individuals with LTBI (n  20), HIV/LTBI (n  15), PTB (n  67), or
HIV/PTB (n 8). All the possible combinations of the responses are shown on the x axis, and the percentages of the functionally distinct cell populations within
(Continued on next page)
HIV Infection Impairs M. tuberculosis-Speciﬁc T Cells Journal of Virology
March 2019 Volume 93 Issue 5 e01728-18 jvi.asm.org 5
To further characterize the cytokine proﬁle of M. tuberculosis-speciﬁc T-cells, multi-
plex bead array analyses were performed on supernatants collected from ESAT-6/
CFP-10 peptide pool (M. tuberculosis)-stimulated cell cultures. The cumulative data
showed that M. tuberculosis-stimulated cell culture supernatants of individuals with
HIV/LTBI or HIV/PTB secreted signiﬁcantly lower levels of IL-2, IL-17A, IL-17F, and IL-21
(P 0.05) than M. tuberculosis-stimulated cell culture supernatants of individuals with
LTBI or with PTB, respectively (Fig. 2C). In addition, M. tuberculosis-stimulated cell
culture supernatants of individuals with HIV/PTB secreted signiﬁcantly lower levels of
TNF-, IL-5, and IL-10 (P 0.05) and reduced levels of IL-13 (borderline signiﬁcance;
P 0.13) than M. tuberculosis-stimulated cell culture supernatants of individuals with
PTB (Fig. 2C). Interestingly, M. tuberculosis-stimulated cell culture supernatants of
individuals with PTB secreted signiﬁcantly lower levels of IL-17A than cell culture
supernatants individuals with LTBI (P 0.05) (Fig. 2C).
Taken together, our data indicate that HIV infection strongly inﬂuences M.
tuberculosis-speciﬁc memory CD4 T-cell frequencies and cytokine proﬁle, among which
IL-2, IL-17A/F, and IL-21 production/secretion capacity appeared to be the most im-
pacted, independently of M. tuberculosis disease status.
HIV infection signiﬁcantly inﬂuences Gata-3, T-bet, and RORt expression.
Since HIV infection signiﬁcantly inﬂuenced Th1, Th2, and Th17 cytokine production/
secretion, we then determined whether HIV infection was associated with changes in
the expression of Th1-, Th2-, and Th17-speciﬁc cell lineage transcription factors T-bet,
Gata-3, and RORt, respectively (22–24).
The combined data showed that the percentages of memory CD4 T cells expressing
Gata-3 or RORt were signiﬁcantly reduced in individuals with HIV/LTBI or HIV/PTB
compared to those in individuals with LTBI or PTB (Gata-3, 2.4% and 2% versus 6.7%
and 6.4%, respectively [P 0.05]; RORt, 1.1% and 0.8% versus 2% and 1.9%, respec-
tively [P 0.05]) (Fig. 3A and B). In contrast, the percentage of memory CD4 T cells
expressing high levels of T-bet (T-bethigh) was signiﬁcantly increased in individuals with
HIV/LTBI or HIV/PTB compared to that in individuals with LTBI or PTB (13% and 17%
versus 0.9% and 3.4%, respectively [P 0.05]) (Fig. 3C). Notably, the frequencies of
memory CD4 T cells expressing T-bethigh were signiﬁcantly higher in individuals with
PTB than in individuals with LTBI (3.4% versus 0.9% [P 0.05]) (Fig. 3C). Interestingly,
the percentage of T-bethigh memory CD4 T cells was inversely correlated with the
percentage of memory CD4 T cells expressing Gata-3 (r  0.6685; P 0.0001) (Fig.
3D), supporting previous observations (25).
We then determined whether theM. tuberculosis-speciﬁc CD4 T-cell cytokine proﬁles
observed in individuals with LTBI or PTB coinfected or not with HIV were associated
with T-bet, Gata-3, or RORt expression proﬁles. To address this issue, we plotted the
percentage of M. tuberculosis-speciﬁc CD4 T cells producing IFN- or IL-4/5/13 against
the percentage of memory CD4 T cells expressing T-bethigh or Gata-3 from the same
patients (Fig. 3E and F) or the levels of IL-17A/F detected in M. tuberculosis-stimulated
cell culture supernatants against the percentage of memory CD4 T cells expressing
RORt from the same patients (Fig. 3G). The cumulative data demonstrate that the
percentage of IFN--producing M. tuberculosis-speciﬁc CD4 T cells directly correlated
with the percentage of T-bethigh memory CD4 T cells (r 0.4599; P 0.0002) (Fig. 3E)
and the percentage of IL-4/5/13-producing M. tuberculosis-speciﬁc CD4 T cells directly
FIG 2 Legend (Continued)
the M. tuberculosis-speciﬁc CD4 T-cell populations are shown on the y axis. Responses are grouped and color-coded on the basis of the number of functions.
The pie chart summarizes the data, and each slice corresponds to the fraction of M. tuberculosis-speciﬁc CD4 T cell response with a given number of functions
within the responding CD4 T-cell population. Bars correspond to the fractions of different functionally distinct CD4 T-cell populations within the total CD4 T
cells. The red arc corresponds to IL-4/5/13-producing CD4 T-cell populations. (C) Levels of IFN-, TNF-, IL-2, IL-4, IL-5, IL-13, IL-10, IL-17A, IL-17F, IL-21, and IL-22
produced in M. tuberculosis-stimulated culture supernatants of individuals with LTBI (n  9), HIV/LTBI (n  9), PTB (n  50), or HIV/PTB (n  8) assessed by
multiplex bead array analyses (Luminex). Undetectable values were arbitrarily deﬁned as 0.1 pg/ml. Individuals were color coded (A to C); Individuals with LTBI,
blue; individuals with HIV/LTBI, red; individuals with PTB, green and individuals with HIV/PTB, orange. Red asterisks indicate statistical signiﬁcance. Statistical
signiﬁcance (P 0.05) was calculated using one-way ANOVA (Kruskal-Wallis test) followed by a Mann-Whitney test (A and C). Statistical analyses of the global
cytokine proﬁles (pie charts) (B) were performed by partial permutation tests using the SPICE software as described previously (54).
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FIG 3 HIV infection signiﬁcantly inﬂuences Gata-3, T-bet, and RORt expression. (A to C) Percentages of memory
(CD45RA) CD4 T cells isolated from individuals with LTBI (n 14), HIV/LTBI (n 12), PTB (n 29), or HIV/PTB (n
8) expressing Gata-3 (A), RORt (B), or T-bethigh (C). (D) Correlation between the percentage of memory CD4 T cells
expressing T-bethigh and the percentage of memory CD4 T cells expressing Gata-3 in individuals with LTBI (n 14),
HIV/LTBI (n  12), PTB (n  26), or HIV/PTB (n  8). (E) Correlation between the percentage of IFN--producing M.
tuberculosis-speciﬁc CD4 T cells and the percentage of memory CD4 T cells expressing T-bethigh of individuals with
LTBI (n  14), HIV/LTBI (n  12), PTB (n  29), or HIV/PTB (n  8). (F) Correlation between the percentage of
IL-4/5/13-producing M. tuberculosis-speciﬁc CD4 T cells and the percentage of memory CD4 T cells expressing
Gata-3 of TB patients from individuals with LTBI (n  14), HIV/LTBI (n  12), PTB (n  29), or HIV/PTB (n  8). (G)
Correlation between the levels of IL-17A/F detected in M. tuberculosis-stimulated culture supernatants and the
percentage of memory CD4 T cells expressing RORt individuals of individuals with LTBI (n  9), HIV/LTBI (n  6),
PTB (n  26), or HIV/PTB (n  8). (H) Correlation between the percentage of memory CD4 T cells expressing Gata-3
and the percentage ofM. tuberculosis-speciﬁc CD4 T cells producing IFN- in individuals with LTBI (n 14), HIV/LTBI
(n  12), PTB (n  26), or HIV/PTB (n  8). (I) Correlation between the percentage of T-bethigh and the percentage
of M. tuberculosis-speciﬁc CD4 T cells producing IL-4/5/13 in individuals with LTBI (n  14), HIV/LTBI (n  12), PTB
(n 26), or HIV/PTB (n 8). Statistical signiﬁcance (*; P 0.05) was calculated using one way Anova (Kruskal-Wallis
test) followed by a Mann-Whitney test (A to C) or Spearman rank test for correlations (D to I). NS, not signiﬁcant.
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correlated with the percentage of memory CD4 T cells expressing Gata-3 (r 0.4085;
P 0.0011) (Fig. 3F). In addition, the levels of IL-17A/F detected in M. tuberculosis-
stimulated cell culture supernatant directly correlated with the percentage of memory
CD4 T cells expressing RORt from the same patients (r 0.3349; P 0.0187) (Fig. 3G).
Notably, the percentages of Gata-3 and T-bethigh memory CD4 T cells negatively
correlated with the percentage of M. tuberculosis-speciﬁc CD4 T cells producing IFN-
and IL-4/5/13, respectively (Gata-3 versus IFN-, r  0.3707 and P 0.05; T-bethigh
versus IL-4/5/13, r  0.3476 and P 0.05) (Fig. 3H and I).
Taken together, these data indicate that HIV infection strongly inﬂuenced Gata-3,
RORt, and T-bethigh T-cell lineage transcription factor expression proﬁles. In particular,
HIV coinfection resulted in a signiﬁcant shift of the M. tuberculosis-speciﬁc cytokine
proﬁle from a mixed Th1/Th2/Th17 cytokine proﬁle associated with increased Gata-3
and RORt and reduced T-bethigh expression observed in individuals with LTBI or PTB
to a Th1-restricted cytokine proﬁle associated with increased T-bethigh and reduced
Gata-3 or RORt expression observed in individuals with HIV/LTBI or HIV/PTB.
HIV infection inﬂuences PD-1 expression onM. tuberculosis-speciﬁc CD4 T cells.
Our data showed that HIV infection signiﬁcantly reduced IL-2 production/secretion
from M. tuberculosis-speciﬁc CD4 T cells. Since IL-2 production/secretion capacity might
be reduced in effector memory cells (EM; CD45RA CCR7) and/or by coinhibitory
molecule expression (26, 27), we therefore assessed whether HIV infection might have
inﬂuenced CCR7 and/or PD-1 surface expression on M. tuberculosis-speciﬁc CD4 T cells.
The percentage of M. tuberculosis-speciﬁc memory CD4 T cells expressing PD-1 was
signiﬁcantly increased in individuals with HIV/LTBI and HIV/PTB compared to individ-
uals with LTBI and PTB, respectively (51% and 38% versus 17% and 24%; P 0.05)
(Fig. 4A and B). In contrast, the percentages of M. tuberculosis-speciﬁc memory CD4 T
cells expressing CCR7 did not differ between individuals with HIV/LTBI or HIV/PTB and
individuals with LTBI or PTB (P 0.05) (Fig. 4A and C).
We then investigated whether the M. tuberculosis-speciﬁc CD4 T-cell cytokine proﬁles
observed in individuals with LTBI or PTB coinfected or not with HIV were associated with
PD-1 expression. To address this issue, we plotted the proportion ofM. tuberculosis-speciﬁc
CD4 T cells producing IL-2 (either total IL-2-producingM. tuberculosis-speciﬁc memory CD4
T cells or IFN-/IL-2/TNF--producing M. tuberculosis-speciﬁc memory CD4 T cells) against
the percentage of M. tuberculosis-speciﬁc memory CD4 T cells expressing PD-1 from the
same patients (Fig. 4D and E). The cumulative data showed that the percentage of M.
tuberculosis-speciﬁc CD4 T cells expressing PD-1 inversely correlated with the proportion of
IL-2-producingM. tuberculosis-speciﬁc memory CD4 T cells (r0.5781; P 0.0001) (Fig.
4D) or the proportion of IFN-/IL-2/TNF--producing M. tuberculosis-speciﬁc memory
CD4 T cells (r  0.4798; P 0.0007) (Fig. 4E).
These data indicate that PD-1 expression on M. tuberculosis-speciﬁc CD4 T cells is
induced by HIV infection and associated with reduced IL-2 production/secretion by M.
tuberculosis-speciﬁc CD4 T cells.
HIV infection did not inﬂuence HAd5-speciﬁc CD4 T-cell frequencies, cytokine
proﬁles, or PD-1 expression. In order to determine whether HIV infection speciﬁcally
inﬂuenced M. tuberculosis-speciﬁc CD4 T-cell responses in the present study, HAd5-
speciﬁc CD4 T-cell responses were also assessed in LTBI with or without HIV coinfection.
The cumulative data indicated that the frequencies and cytokine proﬁles of HAd5-
speciﬁc CD4 T cells were not signiﬁcantly inﬂuenced by HIV infection (P 0.05) (Fig. 5A
and B). In addition, the percentages of HAd5-speciﬁc CD4 T cells expressing PD-1
and/or CCR7 did not signiﬁcantly differ between individuals with LTBI and individuals
with HIV/LTBI (P 0.05) (Fig. 5C and D). Taken together, these data indicated that in
contrast to the case with M. tuberculosis-speciﬁc CD4 T cells, HIV infection inﬂuenced
neither HAd5-speciﬁc CD4 T-cell frequencies nor their cytokine proﬁles or PD-1 expres-
sion.
HIV infection inﬂuences IL-2 production fromM. tuberculosis-speciﬁc CD8 T-cell
responses.M. tuberculosis-speciﬁc CD8 T cells are more frequently detected in PTB than
in LTBI (25, 28, 29). However, the impact of HIV infection on M. tuberculosis-speciﬁc CD8
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T-cell responses remained to be addressed. We therefore investigated whether HIV
infection might inﬂuence the proportion of individuals with detectable M. tuberculosis-
speciﬁc CD8 T cells and the cytokine proﬁle of M. tuberculosis-speciﬁc CD8 T cells of
individuals with LTBI or PTB coinfected or not with HIV. The ability of M. tuberculosis-
speciﬁc CD8 T cells to produce IFN-, TNF-, and/or IL-2 was assessed in 20 LTBI and 67
PTB individuals and compared to that of CD8 T cells from 15 HIV/LTBI- and 10
HIV/PTB-coinfected individuals by ﬂow cytometry. As shown in Fig. 6A, the proportions
of subjects with detectableM. tuberculosis-speciﬁc CD8 T cells did not signiﬁcantly differ
FIG 4 HIV infection inﬂuences PD-1 expression on M. tuberculosis-speciﬁc CD4 T cells. (A) Representative ﬂow
cytometry proﬁle of M. tuberculosis-speciﬁc memory (CD45RA) CD4 T cells (blue dots) isolated from one individual
with LTBI (62021), HIV/LTBI (26), PTB (60064), or HIV/PTB (897) expressing PD-1 and/or CCR7. (B and C) Percentages
of M. tuberculosis-speciﬁc CD4 T cells isolated from individuals with LTBI (n  7), HIV/LTBI (n  15), PTB (n  16),
or HIV/PTB (n  8) expressing PD-1 (B) and/or CCR7 (C). (D and E) Correlation between the percentage of M.
tuberculosis-speciﬁc CD4 T cells expressing PD-1 and the percentage of total IL-2-producing M. tuberculosis-speciﬁc
memory CD4 T cells (D) or the percentage of IFN-/IL-2/TNF--producing M. tuberculosis-speciﬁc memory CD4 T
cells of individuals with LTBI (n  7), HIV/LTBI (n  15), PTB (n  16) or HIV/PTB (n  8) (E). Statistical signiﬁcance
(*; P 0.05) was calculated using one-way ANOVA (Kruskal-Wallis test) followed by the Mann-Whitney test (B and
C) or Spearman rank test for correlation (D and E).
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FIG 5 HIV infection did not inﬂuence HAd5-speciﬁc CD4 T-cell frequencies, cytokine proﬁles, or PD-1 expression.
(A) Percentages of HAd5-speciﬁc CD4 T cells producing IFN-, TNF-, IL-2, or IL-4/5/13 of individuals with LTBI (n 
9) or HIV/LTBI (n  10). (B) Proportion of HAd5-speciﬁc CD4 T-cell populations producing IFN-, IL-4/5/13, TNF-,
and/or IL-2 of individuals with LTBI (n  9) or HIV/LTBI (n  10). All the possible combinations of the responses are
shown on the x axis, and the percentages of the functionally distinct cell populations within the HAd5-speciﬁc CD4
T-cell populations are shown on the y axis. Responses are grouped and color-coded on the basis of the number
of functions. The pie chart summarizes the data, and each slice corresponds to the fraction of HAd5-speciﬁc CD4
T cell response with a given number of functions within the responding CD4 T-cell population. Bars correspond to
the fractions of different functionally distinct CD4 T-cell populations within the total CD4 T cells. (C and D)
(Continued on next page)
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between individuals with HIV/LTBI or HIV/PTB and individuals with LTBI or PTB, respec-
tively (7% versus 0% and 80% versus 46%; P 0.05) (Fig. 6A). Due to the limited
number of LTBI and HIV/LTBI subjects with detectable M. tuberculosis-speciﬁc CD8 T
cells (Fig. 6A), M. tuberculosis-speciﬁc CD8 T-cell frequencies, cytokine proﬁle and
phenotype were restricted to individuals with PTB (Fig. 6B). The cumulative data
indicated that the frequencies of IL-2-producing M. tuberculosis-speciﬁc CD8 T cells
were signiﬁcantly reduced in individuals with HIV/PTB compared to individuals with
PTB (P 0.05), while frequencies of IFN-- or TNF--producing M. tuberculosis-speciﬁc
CD8 T cells did not signiﬁcantly differ between individuals with PTB and individuals
with HIV/PTB (P 0.7202 and P 0.4585, respectively) (Fig. 6B). The cytokine proﬁles of
M. tuberculosis-speciﬁc CD8 T-cell responses in PTB versus HIV/PTB differed signiﬁcantly
(P 0.05) (Fig. 6C, pie charts). A signiﬁcant loss of polyfunctional IFN- IL-2 TNF-
-producing M. tuberculosis-speciﬁc CD8 T cells in individuals with HIV/PTB compared
to individuals with PTB (0% versus 23%; P 0.05) (Fig. 6C) was observed.
Next we measured the PD-1 expression level of M. tuberculosis-speciﬁc CD8 T cells.
The cumulative data indicate that PD-1 expression was signiﬁcantly increased on M.
tuberculosis-speciﬁc memory CD8 T cells in HIV/PTB compared to PTB (P 0.05) (Fig. 6D),
indicating that HIV infection strongly inﬂuenced PD-1 expression onM. tuberculosis-speciﬁc
CD8 T cells and was associated with reduced IL-2 production capacity.
Inﬂuence of HIV replication on M. tuberculosis-speciﬁc CD4 T-cell cytokine
proﬁle and phenotype. Previous studies indicated that in HIV-infected individuals, the
level of PD-1 expression was increased on HIV-speciﬁc T cells but not on cytomegalo-
virus (CMV)- or Epstein-Barr virus (EBV)-speciﬁc T cells (18, 19). In addition, PD-1
expression level directly correlated with HIV viral load, suggesting that excessive and
continuous antigen stimulation functionally impaired HIV-speciﬁc T cells (17, 30).
However, the impact of ongoing HIV replication on M. tuberculosis-speciﬁc CD4 T cells
remains unclear. We then determined whether M. tuberculosis-speciﬁc CD4 T-cell
cytokine proﬁles observed in M. tuberculosis/HIV-coinfected individuals were associated
with HIV viral load. To address this issue, we plotted the proportion of M. tuberculosis-
speciﬁc CD4 T cells producing IL-2 (either total IL-2-producing M. tuberculosis-speciﬁc
memory CD4 T cells or IFN-/IL-2/TNF--producing M. tuberculosis-speciﬁc memory
CD4 T cells) or expressing PD-1 against HIV viral load (Fig. 7). Our results show that the
proportion of M. tuberculosis-speciﬁc CD4 T cells producing IL-2 or the percentage of M.
tuberculosis-speciﬁc CD4 T cells expressing PD-1 did not correlate with HIV viral load
(r0.0051, r0.0735, and r0.0017; P 0.05; respectively) (Fig. 7), suggesting
that the degree of M. tuberculosis-speciﬁc CD4 T-cell impairment was independent of
ongoing HIV replication.
HIV infection dampens the level of systemic inﬂammation markers in PTB/HIV-
coinfected individuals. One objective of the present study was to determine whether
HIV infection may inﬂuence systemic inﬂammation markers in the Tanzanian cohort
studied. Hence, the serum levels of IL-1, IL-6, C-reactive protein (CRP), IL-23, and IP-10
were assessed in individuals with LTBI or PTB coinfected or not with HIV using a
multiplex bead assay (Fig. 8). Notably, the serum levels of IL-6, CRP, and IP-10 were
signiﬁcantly increased in individuals with PTB compared to individuals with LTBI or
HIV/LTBI (P 0.05), supporting previous observations (31) (Fig. 8). Interestingly, the
serum levels of IL-1, IL-6, CRP, IL-23, and IP-10 were signiﬁcantly reduced in individuals
with HIV/PTB compared to individuals with PTB (P 0.05) (Fig. 8).
Taken together, these data suggest that HIV infection signiﬁcantly interferes with
M. tuberculosis-induced systemic proinﬂammatory cytokine/chemokine responses.
FIG 5 Legend (Continued)
Percentages of HAd5-speciﬁc CD4 T cells isolated from individuals with LTBI (n 9) or HIV/LTBI (n 10) expressing
PD-1 (C) and/or CCR7 (D). Statistical signiﬁcance (*; P 0.05) was calculated using the Mann-Whitney test (A, C, and
D). Statistical analyses of the global cytokine proﬁles (pie charts [B]) were performed by partial permutation tests
using the SPICE software as described previously (54).
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FIG 6 HIV infection inﬂuences IL-2 production from M. tuberculosis-speciﬁc CD8 T-cell responses. (A) Proportions of
subjects with detectable M. tuberculosis-speciﬁc CD8 T cells. (B) Percentages of M. tuberculosis-speciﬁc CD8 T cells
producing TNF-, IFN-, and/or IL-2 of individuals with PTB (n  31) or HIV/PTB (n  8). Undetectable values were
arbitrarily deﬁned as 0.01%. (C) Cytokine proﬁle of M. tuberculosis-speciﬁc CD8 T cells of individuals with PTB (n 
31) or HIV/PTB (n  8). The red arc identiﬁes IL-2-producing cell populations (C). (D) Percentage of M. tuberculosis-
speciﬁc CD8 T cells expressing PD-1 of individuals with PTB (n  12) or HIV/PTB (n  8). Statistical signiﬁcance (*;
P 0.05) was calculated using chi-square test (A) and Mann-Whitney test (B and D). Statistical analyses of the
global cytokine proﬁles (pie charts [B] and panel C) were performed by partial permutation tests using the SPICE
software as described previously (54).
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DISCUSSION
Previous studies indicate that the cytokine proﬁle and the frequencies of M.
tuberculosis-speciﬁc CD4 T cells could be impacted by HIV coinfection (14, 15, 32) and
that these responses were not fully restored under cART (12, 13). In the present study,
we hypothesized that progression from LTBI to PTB might not be due to CD4 T-cell
depletion only but might also be driven by M. tuberculosis-speciﬁc CD4 and CD8 T-cell
functional impairment. To test this hypothesis, we assessed the cytokine proﬁle, the
transcription factor expression proﬁle, and the phenotype of M. tuberculosis-speciﬁc T
cells of untreated Tanzanian individuals suffering from LTBI or PTB and compared them
to those of untreated M. tuberculosis/HIV-coinfected individuals suffering from LTBI
or PTB.
We showed that HIV-infected individuals harbored reduced M. tuberculosis-speciﬁc
CD4 T-cell frequencies associated with signiﬁcant changes in M. tuberculosis-speciﬁc
CD4 T-cell cytokine proﬁles. Interestingly, HIV infection did not inﬂuence all cytokines
to the same extent. In particular, we showed that HIV infection signiﬁcantly reduced the
proportion of IL-2- or Th2 (IL-4/IL-5/IL-13)-producing M. tuberculosis-speciﬁc CD4 T cells
in LTBI or PTB. These data, however, contrast with a recent study that did not report
signiﬁcant changes in IL-2 production although changes in M. tuberculosis-speciﬁc CD4
T-cell cytokine proﬁles were observed (15). These differences might be attributed at
least in part to the cohort studied, i.e., South African versus Tanzanian individuals.
Indeed, we recently observed that M. tuberculosis-speciﬁc CD4 T-cell cytokine proﬁle of
PTB patients from Tanzania were primarily composed of polyfunctional Th1 and Th2
cells, whileM. tuberculosis-speciﬁc CD4 T-cell cytokine proﬁles of TB patients from South
Africa were dominated by single IFN- and dual IFN-/TNF- (25).
In addition, we showed that M. tuberculosis/HIV-coinfected individuals harbored
reduced capacity to secrete IL-17A, IL-17F, and IL-21 cytokines following in vitro M.
FIG 7 Inﬂuence of HIV replication on M. tuberculosis-speciﬁc CD4 T-cell cytokine proﬁle and phenotype. Correlation
between the levels HIV-1 RNA and the proportion of total IL-2-producing M. tuberculosis-speciﬁc memory CD4 T
cells (A) or the proportion of IFN-/IL-2/TNF--producing M. tuberculosis-speciﬁc memory CD4 T cells (B) or the
percentage of M. tuberculosis-speciﬁc CD4 T cells expressing PD-1 (C) of individuals HIV/LTBI (n  15) or HIV/PTB
(n  8). Statistical signiﬁcance (*; P 0.05) was calculated using the Spearman rank test for correlation.
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tuberculosis antigen stimulations, supporting previous observations for LTBI subjects
(33) and suggesting that Th17 cells may contribute to control of M. tuberculosis
replication.
Interpretation of cytokine production from stimulated cells remains challenging,
especially within individuals with disease. Notably, the reduced cytokine levels ob-
served in some individuals might be associated with reduced M. tuberculosis-speciﬁc
T-cell frequencies and/or functional impairment. In addition, various parameters such as
transcription factor expression (22, 23), memory subsets (26), and/or the expression of
coinhibitory molecules (17–19, 27) could inﬂuence the cytokine proﬁle of antigen-
speciﬁc CD4 T cells. Here we demonstrate that changes of M. tuberculosis-speciﬁc CD4
T-cell cytokine proﬁles in M. tuberculosis/HIV-coinfected individuals was associated with
an increase of T-bet and PD-1 expression accompanied by a reduction of Gata-3 and
RORt expression in the memory CD4 T cells. The proportion of IL-4/5/13-producing
M. tuberculosis-speciﬁc CD4 T cells was inversely correlated with the percentage of
memory CD4 T cells expressing T-bethigh, and the proportion of IL-2-producing M.
tuberculosis-speciﬁc CD4 T cells was inversely correlated with the percentage of PD-1-
expressing M. tuberculosis-speciﬁc CD4 T cells. Consistent with previous studies, we did
not observe any inﬂuence of HIV infection on the differentiation proﬁle of M.
tuberculosis-speciﬁc CD4 T cells (15, 34), indicating that HIV infection might inﬂuence
the M. tuberculosis-speciﬁc CD4 T-cell cytokine proﬁle by inﬂuencing the transcription
factor proﬁle and PD-1 expression. Several clinical studies performed in multidrug-
resistant TB cases showed an increased rate ofMycobacterium clearance associated with
radiological lung improvement when recombinant IL-2 was applied (35).
To determine whether HIV infection might speciﬁcally impactM. tuberculosis-speciﬁc
CD4 T-cell responses, we also assessed HAd5-speciﬁc T-cell responses in LTBI with or
without HIV coinfection in the same volunteers. HAd5 is an intracellular pathogen that
FIG 8 HIV infection dampens the level of systemic inﬂammation markers in PTB/HIV-coinfected individ-
uals. Shown are serum levels of IL-1, IL-6, CRP, IL-23, and IP-10 of individuals with LTBI (n 11), HIV/LTBI
(n  15), PTB (n  67), or HIV/PTB (n  8). Statistical signiﬁcance (*; P 0.05) was calculated using the
Mann-Whitney test.
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usually causes upper and lower respiratory tract infections (36), controlled by efﬁcient
polyfunctional CD4 and CD8 T-cell responses (37–39), leading to persistent sub-clinical
infections in most of immunocompetent individuals (40, 41). In contrast, in immuno-
compromised individuals, reactivation of HAd5 replication can lead to fatal disease
progression (40). Interestingly, HAd5-speciﬁc CD4 T-cell frequencies, cytokine proﬁles,
and phenotypes did not differ between HIV-uninfected and HIV-infected individuals,
suggesting that HIV infection might speciﬁcally inﬂuence M. tuberculosis-speciﬁc CD4
T-cell responses. Notably, we cannot exclude that distinct scenario or set of circum-
stances were associated with these observations. However, neither the proportion
of IL-2-producing M. tuberculosis-speciﬁc CD4 T cells nor the level of PD-1 on M.
tuberculosis-speciﬁc CD4 T cells of M. tuberculosis/HIV-coinfected individuals corre-
lated with HIV viral load, suggesting that the inﬂuence of HIV infection on M.
tuberculosis-speciﬁc CD4 T-cell cytokine proﬁle and phenotype might be indirect.
The fact that the cytokine proﬁles of M. tuberculosis-speciﬁc CD8 T-cell responses in
PTB versus HIV/PTB differed signiﬁcantly provides additional evidence that HIV
infection may substantially inﬂuence M. tuberculosis-speciﬁc T-cell responses during
active TB disease and echoes the recent ﬁndings from Chiacchio et al. that showed
that M. tuberculosis-speciﬁc CD8 T cells from M. tuberculosis/HIV-coinfected individ-
uals are more monofunctional (42).
One potential mechanism by which HIV infection may inﬂuence TB disease progres-
sion and therefore M. tuberculosis-speciﬁc T-cell cytokine proﬁle and phenotype might
be through granuloma disorganization. Indeed, M. tuberculosis replication is partially
contained by organized granulomas formed by macrophages and CD4 T cells in the
lung tissues (1), which HIV infection may disrupt through CD4 T-cell depletion, favoring
M. tuberculosis dissemination and extrapulmonary disease (43, 44).
Finally, during PTB, M. tuberculosis-exposed/infected lung macrophages produce
large quantities of proinﬂammatory cytokines and chemokines involved in the che-
moattraction of monocytes and T cells to the sites of infection (45, 46). These cytokines/
chemokines are detectable in the sera of individuals with PTB, and the serum cytokine
proﬁle may be indicative of the level of systemic inﬂammation, antigen load, TB disease
severity, and hospitalization duration (47). Therefore, in the present study, we were
interested in how and if HIV infection may interfere with M. tuberculosis-induced
cytokine/chemokine production. We compared the serum levels of proinﬂammatory
cytokines and chemokines of individuals with LTBI and PTB coinfected or not with HIV.
We found that the serum levels of IL-1, IL-6, CRP, IL-23, and IP-10 were signiﬁcantly
reduced in HIV/PTB-coinfected individuals compared to the levels in individuals with
PTB only, suggesting that HIV infection signiﬁcantly dampens M. tuberculosis-induced
systemic proinﬂammatory cytokine/chemokine response.
The mechanism by which HIV suppresses the M. tuberculosis-induced systemic
proinﬂammatory cytokine response in PTB requires further investigation. However, one
potential mechanism might be through M. tuberculosis-speciﬁc CD4 T-cell depletion.
Indeed, M. tuberculosis-induced systemic proinﬂammatory cytokine response in PTB is
mainly mediated by macrophages, epithelial cells, and ﬁbroblasts in response to
proinﬂammatory cytokines released by M. tuberculosis-speciﬁc CD4 T cells (48–50),
which might be reduced in functionally impaired M. tuberculosis-speciﬁc CD4 T cells.
In conclusion, the present study provides evidence thatM. tuberculosis-speciﬁc CD4 and
CD8 T-cell responses are impacted by HIV coinfection, resulting in pronounced variations in
the qualitative and quantitative proﬁle of M. tuberculosis-speciﬁc T cells in human popula-
tions. The precise mechanism by which HIV infection interferes withM. tuberculosis-speciﬁc
protective immunity still remains to be determined and probably involves both the
depletion and the functional impairment of M. tuberculosis-speciﬁc T cells.
MATERIALS AND METHODS
Study group and cell isolation. In total, 112 subjects participated to this study and were recruited
at the Mwananyamala hospital, Dar es Salaam, and at the TB clinic of Bagamoyo (TZ) (Table 1). Pulmonary
TB patients were selected based on sputum smear microscopy conﬁrmed by GeneXpert assay, and HIV
infection was deﬁned based on a rapid serological test (Alere Determine HIV-1/2 test). Individuals with
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no sign of active TB infection but harboring CFP-10/ESAT-6 peptide pool-speciﬁc T-cell responses
assessed by intracellular cytokine staining were classiﬁed as having LTBI. No statistical method was used
to predetermine sample size. Plasma viral load (HIV-1 RNA) was assessed by COBAS AmpliPrep/TaqMan
HIV-1 test (Roche, Switzerland) as previously described (51). Blood mononuclear cells were isolated as
previously described (52).
Ethics statement. All participants were adults and provided written informed consent, and the study
protocol was approved for TZ by the Ethikkomission beider Basel (EKBB; Basel, Switzerland; reference
number 257/08), the Ifakara Health Institute Institutional Review Board, and the National Institute for
Medical Research (NIMR; Dar es Salaam, United Republic of Tanzania; reference number NIMR/HQ/R.8a/
Vol.IX/1098).
Antibodies. The following monoclonal antibodies (MAbs) were used in different combinations:
CD3-allophycocyanin (APC)-H7 (clone SK7), CD4-PECF594 or CD4-APC (clone RPA-T4), CD8-PB (clone
RPA-T8), IFN-–AF700 (clone B27), TNF-–PeCy-7 (clone MAb11), IL-4–phycoerythrin (PE) (clone
3010.211), Gata-3–PeCy–7 (clone L50-823), CCR7-ﬂuorescein isothiocyanate (FITC) (clone 3D12), and
CD8-BV605 (clone SK1), all from Becton, Dickinson (BD); CD45RA-BV711 (clone HI100), IL-2–peridinin
chlorophyll protein (PerCp)–Cy5.5 (clone MQ1-17H12), IL-5–PE (clone TRFK5), IL-13–PE (clone JES10-5A2),
T-bet–PerCp–Cy5.5 (clone 4B10), and PD-1–BV421 (clone EH12.2H7), purchased from BioLegend; and
RORt-PE (clone AFKJS-9) from eBioscience.
Antigens. M. tuberculosis-derived CFP-10 and ESAT-6 peptide pools were composed of 15-mers
overlapping by 11 amino acids encompassing the entire sequences of the proteins, and all peptides were
puriﬁed by high-performance liquid chromatography (HPLC) (90% purity). In some experiments, cells
were also stimulated with 1 g of HAd5 hexon-derived overlapping peptide pool (Miltenyi).
Ex vivo assessment of CD4 and CD8 T-cell cytokine proﬁle by intracellular cytokine staining.
Peripheral blood mononuclear cells (PBMCs) were stimulated overnight in complete medium (RPMI
[Invitrogen], 10% fetal calf serum [FCS; Invitrogen], 100 g/ml of penicillin, 100 U/ml of streptomycin
[BioConcept]) with ESAT-6 and CFP-10 peptide pools (1 g/ml) or with Staphylococcus enterotoxin B (SEB;
250 ng/ml) or with HAd5 hexon-derived overlapping peptide pool, or they were left unstimulated in the
presence of Golgiplug (1 l/ml; BD) as previously described (53). At the end of the stimulation period,
cells were washed and stained (20 min at 4°C) for dead cells using the aqua LIVE/DEAD stain kit
(Invitrogen), washed, and stained (20 min at 4°C) with MAbs to CD3, CD4, CD8, PD-1, CCR7, and CD45RA.
Cells were then permeabilized (30 min at 20°C) (Cytoﬁx/Cytoperm; BD) and stained (20 min at 20°C) with
MAbs to TNF-, IFN-, IL-2, IL-4, IL-5, and IL-13. The criterion for scoring antigen-speciﬁc CD4 or CD8 T-cell
responses as positive was as follows: the cytokine (IFN-, TNF-, or IL-2) frequency obtained in the
sample had to exceed 0.03% after background subtraction.
Assessment of T-bet, Gata-3, and RORt expression. PBMCs were washed, stained (20 min at 4°C)
for dead cells using the aqua LIVE/DEAD stain kit, and then washed and stained (20 min at 4°C) for CD3,
CD4, CD8, and CD45RA. Cells were then washed, permeabilized (45 min at 4°C) (Foxp3 ﬁxation/
permeabilization kit; eBioscience), and stained (20 min at 4°C) with MAbs to T-bet, RORt, and Gata-3.
Assessment of the cytokine proﬁle of M. tuberculosis-stimulated culture supernatants by
multiplex bead assay. PBMCs (2 105 cells) were stimulated for 24 h in complete medium with ESAT-6
and CFP-10 peptide pools (1 g/ml) or with SEB (250 ng/ml) or were left unstimulated (negative control).
At the end of the stimulation period, culture supernatants were collected and levels of TNF-, IFN-, IL-2,
IL-4, IL-5, IL-13, IL-10, IL-17A, IL-17F, IL-21, and IL-22 were assessed cells by multiplex bead assay
(ProcartaPlex Mix&Match Human plex; eBioscience).
Assessment of serum cytokine proﬁle. Serum levels of IL-1, IL-6, IL-23, IL-23, and IP-10 were
assessed by Luminex assay (ProcartaPlex Mix&Match Human plex; eBioscience), and CRP was assessed by
nephelemetry (CardioPhasehsCRP; Siemens Healthcare Diagnostics Products GmbH) as previously de-
scribed (27).
Flow cytometry analyses. Cells were ﬁxed with CellFix (BD), acquired on an LSRII SORP (4 lasers: 405,
488, 532, and 633 nm), and analyzed using FlowJo (version 9.7.7) (Tree Star Inc, Ashland, OR). Frequencies
of cytokine-producingM. tuberculosis-speciﬁc T cells and cytokine proﬁles ofM. tuberculosis-speciﬁc T-cell
responses were analyzed using SPICE software (version 5.34) following background subtraction. When
required, analysis and presentation of distributions was performed using SPICE, downloaded from
http://exon.niaid.nih.gov/spice (54).
Statistical analyses. Statistical signiﬁcance (P values) was determined either using two-tailed
chi-square analysis for comparison of positive proportions or using one-way analysis of variance (ANOVA;
Kruskal-Wallis test) followed by Mann-Whitney test or Wilcoxon matched-pairs two-tailed signed-rank
test for multiple comparisons or Spearman rank test for correlations using GraphPad Prism version 7 (San
Diego, CA). Statistical analyses of global cytokine proﬁles (pie charts) were performed by partial
permutation tests using the SPICE software as described previously (54).
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